| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases
|
Hetterich, Madeleine
|
|
|
187 |
3 |
p. 715-727
|
artikel
|
| 2 |
Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry
|
Kim, Junyup
|
|
|
187 |
3 |
p. 785-792
|
artikel
|
| 3 |
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)
|
Gharzai, Laila A.
|
|
|
187 |
3 |
p. 777-784
|
artikel
|
| 4 |
Association between rice consumption and risk of cancer incidence in the California Teachers Study
|
Austin-Datta, Rebecca J.
|
|
|
187 |
3 |
p. 917-918
|
artikel
|
| 5 |
Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low
|
Cao, Shang
|
|
|
187 |
3 |
p. 793-804
|
artikel
|
| 6 |
Bystander effects induced by electron beam-irradiated MCF-7 cells: a potential mechanism of therapy resistance
|
Feghhi, Maryam
|
|
|
187 |
3 |
p. 657-671
|
artikel
|
| 7 |
Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study
|
Tang, Monica
|
|
|
187 |
3 |
p. 893-902
|
artikel
|
| 8 |
Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells
|
Harati, Rania
|
|
|
187 |
3 |
p. 695-713
|
artikel
|
| 9 |
Comparison of hormone-induced mRNA and protein biomarker expression changes in breast cancer cells
|
Bernhardt, Sarah M.
|
|
|
187 |
3 |
p. 681-693
|
artikel
|
| 10 |
Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer
|
Chun, Jung Whan
|
|
|
187 |
3 |
p. 647-655
|
artikel
|
| 11 |
Concurrent mutations associated with trastuzumab-resistance revealed by single cell sequencing
|
Gao, Yan
|
|
|
187 |
3 |
p. 613-624
|
artikel
|
| 12 |
Delayed initiation of adjuvant chemotherapy among women with breast cancer in Addis Ababa, Ethiopia
|
Gebremariam, Alem
|
|
|
187 |
3 |
p. 877-882
|
artikel
|
| 13 |
Every Day Counts: a randomized pilot lifestyle intervention for women with metastatic breast cancer
|
Sheean, Patricia
|
|
|
187 |
3 |
p. 729-741
|
artikel
|
| 14 |
Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study
|
Falcone, Mary
|
|
|
187 |
3 |
p. 831-841
|
artikel
|
| 15 |
Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial
|
Faltinová, Mária
|
|
|
187 |
3 |
p. 769-775
|
artikel
|
| 16 |
Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy
|
Nguy, Susanna
|
|
|
187 |
3 |
p. 815-830
|
artikel
|
| 17 |
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy
|
Swarnkar, Parinita K.
|
|
|
187 |
3 |
p. 919-920
|
artikel
|
| 18 |
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval
|
Stoen, Ericson
|
|
|
187 |
3 |
p. 883-891
|
artikel
|
| 19 |
Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant trastuzumab: a real-world evidence study
|
O’Shaughnessy, Joyce
|
|
|
187 |
3 |
p. 903-913
|
artikel
|
| 20 |
Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator
|
Johnson, Helen M.
|
|
|
187 |
3 |
p. 805-814
|
artikel
|
| 21 |
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach
|
Swarnkar, Parinita. K.
|
|
|
187 |
3 |
p. 915-916
|
artikel
|
| 22 |
Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer
|
Kumar, Sandeep
|
|
|
187 |
3 |
p. 625-633
|
artikel
|
| 23 |
Survival of women diagnosed with breast cancer and who have survived a previous cancer
|
Pruitt, Sandi L.
|
|
|
187 |
3 |
p. 853-865
|
artikel
|
| 24 |
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
|
Eustace, A. J.
|
|
|
187 |
3 |
p. 635-645
|
artikel
|
| 25 |
Time-varying effects of FOXA1 on breast cancer prognosis
|
Chen, Qian-xin
|
|
|
187 |
3 |
p. 867-875
|
artikel
|
| 26 |
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
|
Huang, Chiun-Sheng
|
|
|
187 |
3 |
p. 759-768
|
artikel
|
| 27 |
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
|
Surette, Alexi
|
|
|
187 |
3 |
p. 743-758
|
artikel
|
| 28 |
Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry
|
Leone, José P.
|
|
|
187 |
3 |
p. 843-852
|
artikel
|
| 29 |
Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials
|
Saini, Geetanjali
|
|
|
187 |
3 |
p. 605-611
|
artikel
|
| 30 |
Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation
|
Moreno, Gustavo
|
|
|
187 |
3 |
p. 673-680
|
artikel
|
Tijdschrift beschrijving